APPLICATION
ANDA076166
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-16
LATEST ACTION
2023-09-27
ROUTE
TRANSDERMAL
DOSAGE FORM
SYSTEM
MARKETING STATUS
Prescription
Products
CLONIDINEPrescription
CLONIDINE 0.2MG/24HR · SYSTEM · TRANSDERMAL
CLONIDINEPrescription
CLONIDINE 0.3MG/24HR · SYSTEM · TRANSDERMAL
CLONIDINEPrescription
CLONIDINE 0.1MG/24HR · SYSTEM · TRANSDERMAL
Approval history
2023-09-27Labeling · Supplement 19 · standardAP
2015-05-18Labeling · Supplement 5 · standardAP
2010-08-24Labeling · Supplement 2AP
2010-07-16OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.